Literature DB >> 2106455

High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.

V C Karande1, G S Jones, L L Veeck, S J Muasher.   

Abstract

In an attempt to improve their outcome with in vitro fertilization (IVF), 34 low-responder patients were stimulated with six ampules of follicle-stimulating hormone (FSH) daily starting on day 1 (n = 17) or day 2 (n = 17) of their menstrual cycles. The stimulated cycles showed a mean peak estradiol of 443 +/- 173 pg/mL, mean days of human chorionic gonadotropin of 7.6 +/- 1.4, 2.67 +/- 1.5 preovulatory oocytes per retrieval, and 2.56 +/- 1.3 oocytes per transfer. Three clinical pregnancies resulted after 25 embryo transfer cycles (12%). With paired analysis, we compared 8 patient cycles with prior six ampules of FSH stimulation starting on day 3; all parameters examined showed no significant differences. In a comparison of 22 patient cycles with prior 4 ampules of FSH stimulation on cycle day 3, no significant differences in any parameters were observed except in the higher number of ampules used in the present study. We conclude that high-dose FSH stimulation at the onset of the menstrual cycle does not improve the IVF outcome in low-responder patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106455     DOI: 10.1016/s0015-0282(16)53345-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.

Authors:  Eun Mi Chang; Ji Eun Han; Hyung Jae Won; You Shin Kim; Tae Ki Yoon; Woo Sik Lee
Journal:  J Assist Reprod Genet       Date:  2011-12-08       Impact factor: 3.412

Review 2.  Management of the poor responder: the role of GnRH agonists and antagonists.

Authors:  Eric S Surrey
Journal:  J Assist Reprod Genet       Date:  2007-11-29       Impact factor: 3.412

Review 3.  Is there a recommended maximum starting dose of FSH in IVF?

Authors:  Luk Rombauts
Journal:  J Assist Reprod Genet       Date:  2007-06-17       Impact factor: 3.412

Review 4.  The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?

Authors:  M H van Hooff
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

Review 5.  Treatment of low responders.

Authors:  S J Muasher
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

6.  "Poor responders": screening and treatment possibilities.

Authors:  F Olivennes; R Fanchin; D De Ziegler; R Frydman
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

7.  Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles.

Authors:  P Kovacs; P E Barg; B R Witt
Journal:  J Assist Reprod Genet       Date:  2001-07       Impact factor: 3.412

8.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

9.  The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples.

Authors:  X M Zhen; J Qiao; R Li; L N Wang; P Liu
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

Review 10.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.